These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2970203

  • 1. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
    Mertens C, Pintens H.
    Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C, Pintens H.
    Acta Psychiatr Scand Suppl; 1989 Jun; 350():140. PubMed ID: 2530770
    [No Abstract] [Full Text] [Related]

  • 3. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 4. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL, Cohn JB, Walshe T, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [Abstract] [Full Text] [Related]

  • 5. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 6. Sleep and paroxetine: a comparison with mianserin in elderly depressed patients.
    Dorman T.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():53-8. PubMed ID: 1431012
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 9. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 May; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 10. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
    Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.
    J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
    [Abstract] [Full Text] [Related]

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 12. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    Acta Psychiatr Scand Suppl; 1989 Apr; 350():117-23. PubMed ID: 2530761
    [Abstract] [Full Text] [Related]

  • 13. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    Acta Psychiatr Scand Suppl; 1989 Apr; 350():125-9. PubMed ID: 2530763
    [Abstract] [Full Text] [Related]

  • 14. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, Mirtazapine vs. Paroxetine Study Group.
    Am J Geriatr Psychiatry; 2002 Apr; 10(5):541-50. PubMed ID: 12213688
    [Abstract] [Full Text] [Related]

  • 15. A double-blind out-patient trial of indalpine vs mianserin.
    Naylor GJ, Martin B.
    Br J Psychiatry; 1985 Sep; 147():306-9. PubMed ID: 3904886
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J, Aubin V.
    Encephale; 2001 Sep; 27(1):71-81. PubMed ID: 11294041
    [Abstract] [Full Text] [Related]

  • 17. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 18. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
    Romeo R, Patel A, Knapp M, Thomas C.
    Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
    [Abstract] [Full Text] [Related]

  • 19. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [Abstract] [Full Text] [Related]

  • 20. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.